Abstract PS2-04-14: Safety of Ribociclib for patients with hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer: the Royal Marsden experience
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Institution: Royal Marsden Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7130717122
Cites:
Cited by:
Related to: